128 related articles for article (PubMed ID: 20882255)
1. Antitumor activity of new hydridotris(pyrazolyl)borate ruthenium(II) complexes containing the phosphanes PTA and 1-CH3-PTA.
García-Fernández A; Díez J; Manteca A; Sánchez J; García-Navas R; Sierra BG; Mollinedo F; Gamasa MP; Lastra E
Dalton Trans; 2010 Nov; 39(42):10186-96. PubMed ID: 20882255
[TBL] [Abstract][Full Text] [Related]
2. Facile modification of 1,3,5-triaza-7-phosphatricyclo[3.3.1.1(3,7)]decane phosphanes coordinated to ruthenium(II).
García-Fernández A; Díez J; Gamasa MP; Lastra E
Inorg Chem; 2009 Mar; 48(6):2471-81. PubMed ID: 19222186
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and DNA binding of new water-soluble cyclopentadienyl ruthenium(II) complexes incorporating phosphines.
Romerosa A; Campos-Malpartida T; Lidrissi C; Saoud M; Serrano-Ruiz M; Peruzzini M; Garrido-Cárdenas JA; García-Maroto F
Inorg Chem; 2006 Feb; 45(3):1289-98. PubMed ID: 16441141
[TBL] [Abstract][Full Text] [Related]
4. Bis(allyl)ruthenium(IV) complexes containing water-soluble phosphane ligands: synthesis, structure, and application as catalysts in the selective hydration of organonitriles into amides.
Cadierno V; Díez J; Francos J; Gimeno J
Chemistry; 2010 Aug; 16(32):9808-17. PubMed ID: 20586085
[TBL] [Abstract][Full Text] [Related]
5. Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis.
Ang WH; Daldini E; Scolaro C; Scopelliti R; Juillerat-Jeannerat L; Dyson PJ
Inorg Chem; 2006 Oct; 45(22):9006-13. PubMed ID: 17054361
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of new enantiopure pybox-ruthenium complexes.
Menéndez-Pedregal E; Díez J; Manteca Á; Sánchez J; Bento AC; García-Navas R; Mollinedo F; Gamasa MP; Lastra E
Dalton Trans; 2013 Oct; 42(38):13955-67. PubMed ID: 23925580
[TBL] [Abstract][Full Text] [Related]
7. Cellular delivery of pyrenyl-arene ruthenium complexes by a water-soluble arene ruthenium metalla-cage.
Furrer MA; Schmitt F; Wiederkehr M; Juillerat-Jeanneret L; Therrien B
Dalton Trans; 2012 Jun; 41(24):7201-11. PubMed ID: 22506276
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, catalytic properties and biological activity of new water soluble ruthenium cyclopentadienyl PTA complexes [(C5R5)RuCl(PTA)2] (R = H, Me; PTA = 1,3,5-triaza-7-phosphaadamantane).
Akbayeva DN; Gonsalvi L; Oberhauser W; Peruzzini M; Vizza F; Brüggeller P; Romerosa A; Sava G; Bergamo A
Chem Commun (Camb); 2003 Jan; (2):264-5. PubMed ID: 12585422
[TBL] [Abstract][Full Text] [Related]
9. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
[TBL] [Abstract][Full Text] [Related]
10. Gold(I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs.
García-Moreno E; Gascón S; Atrián-Blasco E; Rodriguez-Yoldi MJ; Cerrada E; Laguna M
Eur J Med Chem; 2014 May; 79():164-72. PubMed ID: 24732792
[TBL] [Abstract][Full Text] [Related]
11. New water-soluble polypyridine silver(I) derivatives of 1,3,5-triaza-7-phosphaadamantane (PTA) with significant antimicrobial and antiproliferative activities.
Smoleński P; Jaros SW; Pettinari C; Lupidi G; Quassinti L; Bramucci M; Vitali LA; Petrelli D; Kochel A; Kirillov AM
Dalton Trans; 2013 May; 42(18):6572-81. PubMed ID: 23474654
[TBL] [Abstract][Full Text] [Related]
12. Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity.
Banerjee S; Chakravarty AR
Acc Chem Res; 2015 Jul; 48(7):2075-83. PubMed ID: 26158541
[TBL] [Abstract][Full Text] [Related]
13. Use of perfluorinated phosphines to provide thermomorphic anticancer complexes for heat-based tumor targeting.
Renfrew AK; Scopelliti R; Dyson PJ
Inorg Chem; 2010 Mar; 49(5):2239-46. PubMed ID: 20131860
[TBL] [Abstract][Full Text] [Related]
14. Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer.
Sanz Del Olmo N; Bajo AM; Ionov M; García-Gallego S; Bryszewska M; Gómez R; Ortega P; de la Mata FJ
Eur J Med Chem; 2020 Aug; 199():112414. PubMed ID: 32438200
[TBL] [Abstract][Full Text] [Related]
15. Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications.
Selvamurugan S; Ramachandran R; Viswanathamurthi P
Biometals; 2013 Oct; 26(5):741-53. PubMed ID: 23780567
[TBL] [Abstract][Full Text] [Related]
16. Phenanthroline ligands are biologically more active than their corresponding ruthenium(II) arene complexes.
Valladolid J; Hortigüela C; Busto N; Espino G; Rodríguez AM; Leal JM; Jalón FA; Manzano BR; Carbayo A; García B
Dalton Trans; 2014 Feb; 43(6):2629-45. PubMed ID: 24327227
[TBL] [Abstract][Full Text] [Related]
17. Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents.
Gras M; Therrien B; Süss-Fink G; Zava O; Dyson PJ
Dalton Trans; 2010 Nov; 39(42):10305-13. PubMed ID: 20890536
[TBL] [Abstract][Full Text] [Related]
18. New Class of Half-Sandwich Ruthenium(II) Arene Complexes Bearing the Water-Soluble CAP Ligand as an in Vitro Anticancer Agent.
Guerriero A; Oberhauser W; Riedel T; Peruzzini M; Dyson PJ; Gonsalvi L
Inorg Chem; 2017 May; 56(10):5514-5518. PubMed ID: 28443659
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticancer activity of carbosilane metallodendrimers based on arene ruthenium(ii) complexes.
Maroto-Díaz M; Elie BT; Gómez-Sal P; Pérez-Serrano J; Gómez R; Contel M; Javier de la Mata F
Dalton Trans; 2016 Apr; 45(16):7049-66. PubMed ID: 26990859
[TBL] [Abstract][Full Text] [Related]
20. Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity.
Ji L; Zheng W; Lin Y; Wang X; Lü S; Hao X; Luo Q; Li X; Yang L; Wang F
Eur J Med Chem; 2014 Apr; 77():110-20. PubMed ID: 24631730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
